Florida, February 26, 2018:
Transfection Reagents and Equipment Market 2018
The Global Transfection Reagents and Equipment Market is expected to exceed more than US$ 1.0 Billion by 2022 at a CAGR of 7% in the given forecast period.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market.
Key players profiled in the report include
Hoffmann-La Roche Ltd.
Mirus Bio LLC (U.S.), and MaxCyte Inc.
Thermo Fisher Scientific Inc.
Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
Browse full Report: https://www.marketresearchengine.com/transfection-reagents-and-equipment-market
The Global Transfection Reagents and Equipment Market has been segmented as below:
By Product Analysis:
By Method Analysis:
- Calcium Phosphate
- Others (Genegun, Sonoporation, Magnetofection, and Optoinjection)
By Application Analysis:
- Biomedical Research
- Gene Expression Studies
- Cancer Research
- Transgenic Model
- Protein Production
- Therapeutic Deli very
By End User Analysis:
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
By Regional Analysis:
- North America
- Rest of the World
This report provides:
1) An overview of the global market for Nasal Spray Market and related technologies.
2) Analyses of global market trends, with data from 2014, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Transfection Reagents and Equipment Market
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Buy Report from here: https://www.marketresearchengine.com/transfection-reagents-and-equipment-market
Table of Contents:
1.1 KEY TAKE AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
2 Research Methodology
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
220.127.116.11 Key Data From Secondary Sources
2.2.2 Primary Research
18.104.22.168 Key Data From Primary Sources
22.214.171.124 Key Insights From Primary Sources
126.96.36.199 Key Industry Insights
2.3 Market Size Estimation Methodology
2.3.1 Market Forecast Methodology
2.4 Market Data Validation and Triangulation
3 Executive Summary
4 Premium Insights
4.1 Global Transfection Technologies Market
4.2 Transfection Technologies Market, By Application & Region
4.3 Geographic Snapshot: Transfection Technologies Market
4.4 Transfection Technologies Market, By Product (2016 vs 2021)
4.5 Transfection Technologies Market, By End User, 2016 vs 2021 (USD Million)
5 Market Overview
5.2 Market Dynamics
188.8.131.52 Technological Advancements in Transfection Technology
184.108.40.206.3 Three Dimension (3D) Transfection Technology
220.127.116.11 Global Alliances Among Leading Research Institutes to Trigger Drug Discovery
18.104.22.168 Increase in R&D Spending and Research Activities By Pharmaceutical and Biotech Companies
22.214.171.124 Growing Research Activities in Cell Science
126.96.36.199 Increase in Demand for Synthetic Genes
188.8.131.52 Rising Incidence of Cancer Worldwide
184.108.40.206 Selective Effectiveness of Transfection Reagents
220.127.116.11 Home Brew Reagents Restrict Sale of Commercial Kits
18.104.22.168 High Cost of Transfection Reagents
22.214.171.124 Large-Scale Transfections
126.96.36.199 High-Growth Opportunities in Asian Market
188.8.131.52 Transfection in Hard-To-Transfect Cells
184.108.40.206 Cytotoxicity in Transfection – A Major Concern
6 Transfection Technologies Market, By Product
7 Transfection Technologies Market, By Method
7.2 Biochemical Methods
7.2.2 Calcium Phosphate
7.3.3 Other Methods
7.4 Viral Methods
7.4.3 Adenoassociated Viruses (AAV)
8 Transfection Technologies Market, By Application
8.2 Biomedical Research
8.2.1 Gene Expression Studies
8.2.2 Cancer Research
8.2.3 Transgenic Models
8.3 Protein Production
8.4 Therapeutic Delivery
9 Transfection Technologies Market, By End User
9.2 Academics & Research Institutes
9.3 Pharmaceutical & Biotechnology Companies
10 Transfection Technologies Market, By Region
10.2 North America
10.2.1.1 Increase in Bio-Based Drug Research
10.2.1.2 Growing Demand for Protein-Based Therapeutics Triggers the Growth of U.S. Market
10.2.1.3 Increasing Funding for Biotechnology and for Development of Protein-Based Biologics
10.2.2.1 Government Support for Development of Protein Drugs is Expected to Drive the Market for Transfection Technologies
10.2.2.2 Increasing Investments By the Canadian Government on Regenerative Medicine to Drive Market Growth
10.2.2.3 Increasing Funding for Genome Engineering in Canada Likely to Boost Transfection Technologies Market
10.3.1.1 Growing Biotech Industry and Research Funding in Germany
10.3.1.2 Collaboration Among Bio-Pharmaceutical and Biotechnology Companies for the Development of New Vaccines is Likely to Drive the Market Growth
10.3.1.3 Conferences and Meetings/Workshops in Germany
10.3.1.4 Availability of Funding for Life Science Research in Germany
10.3.2.1 10,000 Genome Project Initiative in U.K.
10.3.2.2 Initiative to Increase R&D Investments in U.K.
10.3.3 Rest of Europe
10.3.3.1 Growing Biotechnology and Pharma Industry in Italy
10.3.3.2 Focus on Research in Spain
10.3.3.3 Investments and Funding for Life Sciences to Drive the Transfection Technologies Market
10.3.3.4 Growing Research Investments in Sweden & Denmark
10.4.1.1 Rise in Biomedical Research in Japan
10.4.2.1 Chinese Government Initiatives for Life Sciences R&D Likely to Boost the Market
10.4.2.2 Industry Initiative to Boost Transfection Technology Market in China
10.4.3.1 Booming Pharmaceutical and Biotechnology Industries
10.4.3.2 Development of Bio-Clusters in India
10.4.4 Rest of Asia-Pacific
10.4.4.1 Federal Collaborations in Australia
10.4.4.2 Funding for Research on Proteomics and Genomics in Australia
10.4.4.3 Rising Pharmaceutical and Biotechnology R&D Activities in South Korea
10.4.4.4 Government Support for Strong Academic and Commercial R&D Activities in Taiwan
10.4.4.5 Genome Asia 100k Initative
10.5 Rest of the Word (RoW)
10.5.1 Latin America
10.5.1.1 Increasing Investment in Brazil and Mexico
10.5.1.2 Brazil: Investment in Research and Innovation Centers and Conferences & Workshops
10.5.2 Middle East & Africa
10.5.2.1 Increasing Focus of Major Pharmaceutical, Biopharmaceutical, and Biotechnology Firms in Saudi Arabia and the United Arab Emirates (UAE) and African Regions
10.5.2.2 Genetic Testing and Genomic Analysis in the Middle East
11 Competitive Landscape
11.2 Market Share Analysis
11.2.2 Thermo Fisher Scientific Inc.
11.2.3 Promega Corporation
11.2.4 F. Hoffmann-La Roche Ltd
11.2.5 Qiagen N.V.
11.3 Competitive Situation and Trends
11.4 Agreements, Collaborations and Partnerships
11.5 New Product Launches
11.8 Other Strategies
12 Company Profiles
12.1 Thermo Fisher Scientific Inc. (Life Technologies)
12.2 Promega Corporation
12.3 Qiagen N.V.
12.4 F. Hoffmann-La Roche Ltd
12.5 Bio–Rad Laboratories, Inc.
12.6 Maxcyte, Inc.
12.7 Lonza Group Ltd.
12.8 Merck KGaA
12.9 Polyplus-Transfection Sa (Subsidary of Archimed)
12.10 Mirus Bio LLC.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States